Carregant...
What’s next after metformin? focus on sulphonylurea: add-on or combination therapy
INTRODUCTION: The pathophysiology of type 2 diabetes (T2DM) mainly focused on insulin resistance and insulin deficiency over the past decades. Currently, the pathophysiologies expanded to ominous octet and guidelines were updated with newer generation of antidiabetic drug classes. However, many pati...
Guardat en:
| Publicat a: | Pharm Pract (Granada) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582747/ https://ncbi.nlm.nih.gov/pubmed/26445623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18549/PharmPract.2015.03.606 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|